{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:30:16Z","timestamp":1771954216013,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["304388\/2020-3"],"award-info":[{"award-number":["304388\/2020-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.lfs.2021.120026","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T15:40:26Z","timestamp":1633707626000},"page":"120026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Coadministration of sitagliptin or metformin has no major impact on the adverse metabolic outcomes induced by dexamethasone treatment in rats"],"prefix":"10.1016","volume":"286","author":[{"given":"Bryanne Silva","family":"Figueiredo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francielle Batista D.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Marreiro","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Orts\u00e4ter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Rafacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.120026_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2021.120026_bb0010","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.3390\/ijms22136764","article-title":"Dexamethasone for severe COVID-19: how does it work at cellular and molecular Levels?","volume":"22","author":"Kino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.120026_bb0015","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","article-title":"Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force","volume":"75","author":"Strehl","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2021.120026_bb0020","first-page":"267","article-title":"Dexamethasone in ARDS network. dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020"},{"key":"10.1016\/j.lfs.2021.120026_bb0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/metabo6030024","article-title":"Impact of glucocorticoid excess on glucose tolerance: clinical and preclinical evidence","volume":"6","author":"Pasieka","year":"2016","journal-title":"Metabolites."},{"key":"10.1016\/j.lfs.2021.120026_bb0030","series-title":"State of the Art of Therapeutic Endocrinology","first-page":"121","article-title":"Functional and molecular aspects of glucocorticoids in the endocrine pancreas and glucose homeostasis","author":"Rafacho","year":"2012"},{"key":"10.1016\/j.lfs.2021.120026_bb0035","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/EJE-13-0610","article-title":"Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial","volume":"170","author":"van Genugten","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120026_bb0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/EJE-16-0653","article-title":"Metformin prevents metabolic side effects during systemic glucocorticoid treatment","volume":"176","author":"Seelig","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120026_bb0045","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1590\/1414-431x20153904","article-title":"Effects of exercise and metformin on the prevention of glucose intolerance: a comparative study","volume":"48","author":"Molena-Fernandes","year":"2015","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.lfs.2021.120026_bb0050","first-page":"FC06","article-title":"Comparison of pioglitazone and metformin efficacy against glucocorticoid induced atherosclerosis and hepatic steatosis in insulin resistant rats","volume":"11","author":"Nayak","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.lfs.2021.120026_bb0055","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00774-019-00989-y","article-title":"Preventative effects of metformin on glucocorticoid-induced osteoporosis in rats","volume":"37","author":"Zhao","year":"2019","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.lfs.2021.120026_bb0060","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.2337\/dc21-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2021.120026_bb0065","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2021.120026_bb0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00003495-200767040-00007","article-title":"Sitagliptin","volume":"67","author":"Lyseng-Williamson","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2021.120026_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0030-1269896","article-title":"Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats","volume":"43","author":"Rafacho","year":"2011","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.lfs.2021.120026_bb0080","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1139\/cjpp-2014-0259","article-title":"Age- and gender-related changes in glucose homeostasis in glucocorticoid-treated rats","volume":"92","author":"dos Santos","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120026_bb0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.phrs.2012.05.003","article-title":"Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats","volume":"66","author":"Bagul","year":"2012","journal-title":"Pharmacol. Res."},{"issue":"2013","key":"10.1016\/j.lfs.2021.120026_bb0090","article-title":"Effect of the combination of metformin and fenofibrate on glucose homeostasis in diabetic goto-kakizaki rats","volume":"45","author":"Oh","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2021.120026_bb0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1258\/ebm.2010.010161","article-title":"Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats","volume":"236","author":"Chen","year":"2011","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.lfs.2021.120026_bb0100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/JOE-13-0484","article-title":"Combining sitagliptin\/metformin with a functional fiber delays diabetes progression in zucker rats","volume":"220","author":"Reimer","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120026_bb0105","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biopha.2018.12.036","article-title":"Dipeptidyl peptidase-4 inhibition protects the liver of insulin-resistant female rats against triglyceride accumulation by suppressing uric acid","volume":"110","author":"Omolekulo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2021.120026_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2014.09.024","article-title":"JNK and IKK\u03b2 phosphorylation is reduced by glucocorticoids in adipose tissue from insulin-resistant rats","volume":"145","author":"Motta","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2021.120026_bb0115","first-page":"972","article-title":"Disruption of glucose tolerance caused by glucocorticoid excess in rats is partially prevented, but not attenuated, by arjunolic acid","volume":"52","author":"Gon\u00e7alves-Neto","year":"2014","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.lfs.2021.120026_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108572","article-title":"Impact of combined long-term fructose and prednisolone intake on glucose and lipid homeostasis in rats: benefits of intake interruption or fish oil administration","volume":"90","author":"Santos","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2021.120026_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093531","article-title":"Pancreatic alpha-cell dysfunction contributes to the disruption of glucose homeostasis and compensatory insulin hypersecretion in glucocorticoid-treated rats","volume":"9","author":"Rafacho","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.lfs.2021.120026_bb0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MPA.0b013e31815ba826","article-title":"Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance","volume":"36","author":"Rafacho","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.lfs.2021.120026_bb0135","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/meta.2001.25803","article-title":"Dexamethasone treatment induces long-lasting hyperleptinemia and anorexia in old rats","volume":"50","author":"Caldefie-Ch\u00e9zet","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2021.120026_bb0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apha.12226","article-title":"Chronic glucocorticoid treatment enhances lipogenic activity in visceral adipocytes of male wistar rats","volume":"211","author":"Chimin","year":"2014","journal-title":"Acta Physiol.(Oxf.)"},{"key":"10.1016\/j.lfs.2021.120026_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2015.09.020","article-title":"Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme","volume":"155","author":"Protzek","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2021.120026_bb0150","first-page":"67","volume":"14","author":"Williams-Herman","year":"2012","journal-title":"DiabetesObes. Metab."},{"key":"10.1016\/j.lfs.2021.120026_bb0155","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s12325-013-0072-x","article-title":"Additive postprandial glucose-lowering effects of mitiglinide and sitagliptin in patients with type 2 diabetes mellitus","volume":"30","author":"Jung","year":"2013","journal-title":"Adv. Ther."},{"key":"10.1016\/j.lfs.2021.120026_bb0160","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2337\/db13-1455","article-title":"Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade","volume":"63","author":"Aulinger","year":"2014","journal-title":"Diabetes"},{"issue":"2019","key":"10.1016\/j.lfs.2021.120026_bb0165","article-title":"Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in zucker diabetic fatty rats","volume":"7","author":"Zhang","year":"2019","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.lfs.2021.120026_bb0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12906-016-1221-y","article-title":"The influence of goutweed (Aegopodium podagraria L.) tincture and metformin on the carbohydrate and lipid metabolism in dexamethasone-treated rats","volume":"16","author":"Tovchiga","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.lfs.2021.120026_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.18433\/J3TG7W","article-title":"Swim training reduces metformin levels in fructose-induced insulin resistant rats","volume":"15","author":"Chien","year":"2012","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.lfs.2021.120026_bb0180","doi-asserted-by":"crossref","first-page":"E367","DOI":"10.1152\/ajpendo.00447.2016","article-title":"Effects of metformin on compensatory pancreatic \u03b2-cell hyperplasia in mice fed a high-fat diet","volume":"313","author":"Tajima","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2021.120026_bb0185","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db07-0381","article-title":"Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP","volume":"57","author":"Kim","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2021.120026_bb0190","article-title":"Prevention of elevation in plasma triacylglycerol with high-dose bezafibrate treatment abolishes insulin resistance and attenuates glucose intolerance induced by short-term treatment with dexamethasone in rats","volume":"8","author":"In\u00e1cio","year":"2018","journal-title":"Int. J. Endocrinol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521010134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521010134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:49:05Z","timestamp":1758401345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521010134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":38,"alternative-id":["S0024320521010134"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120026","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coadministration of sitagliptin or metformin has no major impact on the adverse metabolic outcomes induced by dexamethasone treatment in rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120026"}}